TITLE

A Histone Acetyltransferase p300 Inhibitor C646 Induces Cell Cycle Arrest and Apoptosis Selectively in AML1-ETO-Positive AML Cells

AUTHOR(S)
Gao, Xiao-ning; Lin, Ji; Ning, Qiao-yang; Gao, Li; Yao, Yu-shi; Zhou, Ji-hao; Li, Yong-hui; Wang, Li-li; Yu, Li
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
AML1-ETO fusion protein (AE) is generated by t(8;21)(q22;q22) chromosomal translocation, which is one of the most frequently observed structural abnormalities in acute myeloid leukemia (AML) and displays a pivotal role in leukemogenesis. The histone acetyltransferase p300 promotes self-renewal of leukemia cells by acetylating AE and facilitating its downstream gene expression as a transcriptional coactivator, suggesting that p300 may be a potential therapeutic target for AE-positive AML. However, the effects of p300 inhibitors on leukemia cells and the underlying mechanisms have not been extensively investigated. In the current study, we analyzed the anti-leukemia effects of C646, a selective and competitive p300 inhibitor, on AML cells. Results showed that C646 inhibited cellular proliferation, reduced colony formation, evoked partial cell cycle arrest in G1 phase, and induced apoptosis in AE-positive AML cell lines and primary blasts isolated from leukemic mice and AML patients. Nevertheless, no significant inhibitory effects were observed in granulocyte colony-stimulating factor-mobilized normal peripheral blood stem cells. Notably, AE-positive AML cells were more sensitive to lower C646 doses than AE-negative ones. And C646-induced growth inhibition on AE-positive AML cells was associated with reduced global histone H3 acetylation and declined c-kit and bcl-2 levels. Therefore, C646 may be a potential candidate for treating AE-positive AML.
ACCESSION #
87623787

 

Related Articles

  • RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study. Lijing Shen; Jianyi Zhu; Fangyuan Chen; Wenjie Lin; Jiayi Cai; Jihua Zhong; Hua Zhong; Shen, Lijing; Zhu, Jianyi; Chen, Fangyuan; Lin, Wenjie; Cai, Jiayi; Zhong, Jihua; Zhong, Hua // BMC Cancer;12/16/2015, Vol. 15, p1 

    Background: Acute myeloid leukemia (AML) 1-Evi-1 is a chimeric gene generated by the t (3; 21) (q26; q22) translocation, which leads into malignant transformation of hematopoietic stem cells by unclear mechanisms. This in vivo study aimed to establish a stable line of zebrafish...

  • CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells. Wenxiu Qi; Chengzhi Xie; Chunhuai Li; Caldwell, J. Timothy; Edwards, Holly; Taub, Jeffrey W.; Yue Wang; Hai Lin; Yubin Ge // Journal of Hematology & Oncology;2014, Vol. 7 Issue 1, p1 

    Background Acute myeloid leukemia (AML) remains a difficult disease to treat and requires new therapies to improve treatment outcome. Wee1 inhibitors have been used to prevent activation of the G2 cell cycle checkpoint, thus enhancing the antitumor activity of DNA damaging agents. In this study,...

  • Myc interacts with Max and Miz1 to repress C/EBPσ promoter activity and gene expression. Junling Si; Xueyan Yu; Yingjie Zhang; DeWille, James W. // Molecular Cancer;2010, Vol. 9, p92 

    Background: "Loss of function" alterations in CCAAT/Enhancer Binding Proteinδ (C/EBPδ) have been reported in a number of human cancers including breast, prostate and cervical cancer, hepatocellular carcinoma and acute myeloid leukemia. C/EBPδ gene transcription is induced during...

  • MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia. Palma, Catalina A.; Al Sheikha, Dima; Lim, Teck Khai; Bryant, Adam; Vu, Thi Thanh; Jayaswal, Vivek; Ma, David D. F. // Molecular Cancer;2014, Vol. 13 Issue 1, p1 

    Background Acute myeloid leukaemia (AML) is characterised by the halt in maturation of myeloid progenitor cells, combined with uncontrolled proliferation and abnormal survival, leading to the accumulation of immature blasts. In many subtypes of AML the underlying causative genetic insults are...

  • Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells. Kumar, Sanjay; Yedjou, Clement G.; Tchounwou, Paul B. // Journal of Experimental & Clinical Cancer Research (17569966);2014, Vol. 33 Issue 1, p1 

    Background Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML), which accounts for approximately 10% of all acute myloid leukemia cases. It is a blood cancer that is formed by chromosomal mutation. Each year in the United States, APL affects about 1,500 patients of...

  • Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation. Ancker, Willemijn; Luijn, Marvin; Ruben, Jurjen; Westers, Theresia; Bontkes, Hetty; Ossenkoppele, Gert; Gruijl, Tanja; Loosdrecht, Arjan // Cancer Immunology, Immunotherapy;Jan2011, Vol. 60 Issue 1, p37 

    Therapeutic vaccination with dendritic cells (DC) is an emerging investigational therapy for eradication of minimal residual disease in acute myeloid leukemia. Various strategies are being explored in manufacturing DC vaccines ex vivo, e.g., monocyte-derived DC (MoDC) loaded with...

  • Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML. Saito, Yoriko; Uchida, Naoyuki; Tanaka, Satoshi; Suzuki, Nahoko; Tomizawa-Murasawa, Mariko; Sone, Akiko; Najima, Yuho; Takagi, Shinsuke; Aoki, Yuki; Wake, Atsushi; Taniguchi, Shuichi; Shultz, Leonard D.; Ishikawa, Fumihiko // Nature Biotechnology;Mar2010, Vol. 28 Issue 3, p275 

    Cancer stem cells have been proposed to be important for initiation, maintenance and recurrence of various malignancies, including acute myeloid leukemia (AML). We have previously reported that CD34+CD38− human primary AML stem cells residing in the endosteal region of the bone marrow are...

  • Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptosic proteins. Konopleva, M.; Konoplev, S.; Hu, W.; Zaritskey, A.Y.; Afanasiev, B.V.; Andreeff, M. // Leukemia (08876924);Sep2002, Vol. 16 Issue 9, p1713 

    The aim of this study was to study interactions between stromal bone marrow microenvironment and leukemic cells. We tested the hypothesis that stromal cells prevent apoptosis of AML cells by up-regulating anti-apoptotic proteins in leukemic blasts. In HL-60 and NB-4 cells, serum deprivation- and...

  • Epigenetic Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemias. Leone, Giuseppe; D'Alò, Francesco; Zardo, Giuseppe; Voso, Maria Teresa; Nervi, Clara // Current Medicinal Chemistry;2008, Vol. 15 Issue 13, p1274 

    Epigenetic mechanisms affecting chromatin structure contribute to regulate gene expression and assure the inheritance of information, which are essential for the proper expression of key regulatory genes in healthy cells, tissues and organs. In the medical field, an increasing body of evidence...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics